Hoffmann, Emily http://orcid.org/0000-0002-0958-6699
Masthoff, Max
Kunz, Wolfgang G.
Seidensticker, Max
Bobe, Stefanie
Gerwing, Mirjam
Berdel, Wolfgang E. http://orcid.org/0000-0002-3030-6567
Schliemann, Christoph http://orcid.org/0000-0003-1755-9583
Faber, Cornelius
Wildgruber, Moritz http://orcid.org/0000-0002-7228-6963
Article History
Accepted: 4 April 2024
First Online: 19 April 2024
Competing interests
: W.E.B. is CEO of ANTUREC Pharmaceuticals.com and holds patents for vascular targeting of tissue factor. All the other authors declare no conflicts of interest.